DE69001309D1 - Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist. - Google Patents

Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.

Info

Publication number
DE69001309D1
DE69001309D1 DE9090400203T DE69001309T DE69001309D1 DE 69001309 D1 DE69001309 D1 DE 69001309D1 DE 9090400203 T DE9090400203 T DE 9090400203T DE 69001309 T DE69001309 T DE 69001309T DE 69001309 D1 DE69001309 D1 DE 69001309D1
Authority
DE
Germany
Prior art keywords
factor
antihaemophilic
producing
high purity
antihaemophilic factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090400203T
Other languages
English (en)
Other versions
DE69001309T2 (de
Inventor
Bernard Jules Dazey
Mohamed Hamsany
Gerard Paul Vezon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AQUITAINE DEV TRANSF SANGUINE
Original Assignee
AQUITAINE DEV TRANSF SANGUINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9378912&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69001309(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AQUITAINE DEV TRANSF SANGUINE filed Critical AQUITAINE DEV TRANSF SANGUINE
Application granted granted Critical
Publication of DE69001309D1 publication Critical patent/DE69001309D1/de
Publication of DE69001309T2 publication Critical patent/DE69001309T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE9090400203T 1989-02-17 1990-01-24 Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist. Expired - Fee Related DE69001309T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8902136A FR2644064B1 (fr) 1989-02-17 1989-02-17 Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant

Publications (2)

Publication Number Publication Date
DE69001309D1 true DE69001309D1 (de) 1993-05-19
DE69001309T2 DE69001309T2 (de) 1993-08-05

Family

ID=9378912

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9090400203T Expired - Fee Related DE69001309T2 (de) 1989-02-17 1990-01-24 Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.

Country Status (7)

Country Link
EP (1) EP0383645B1 (de)
JP (1) JP2521551B2 (de)
AT (1) ATE88188T1 (de)
DE (1) DE69001309T2 (de)
DK (1) DK0383645T3 (de)
ES (1) ES2055875T3 (de)
FR (1) FR2644064B1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760183A (en) * 1989-02-17 1998-06-02 Association D'aquitaine Pour De Developpment De La Transfusion Sanguine Et Des Recherches Hematologiques Process for the manufacture of very high-purity antithaemophilic factor (FVIIIC), and von Willebrand factor, and pharmaceutical compositions containing same
FR2665449B1 (fr) * 1990-08-02 1995-04-14 Aquitaine Developp Transf Sang Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
DE4111393A1 (de) * 1991-04-09 1992-10-15 Behringwerke Ag Stabilisierte faktor viii-praeparationen
FR2686883B1 (fr) * 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
NL8701915A (nl) * 1987-08-14 1989-03-01 Waander Riethorst Adsorbensmateriaal en toepassing daarvan voor het isoleren van stollingsfaktoren.
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3904354A1 (de) * 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung

Also Published As

Publication number Publication date
FR2644064B1 (fr) 1994-05-27
EP0383645A1 (de) 1990-08-22
DE69001309T2 (de) 1993-08-05
EP0383645B1 (de) 1993-04-14
JP2521551B2 (ja) 1996-08-07
JPH02282400A (ja) 1990-11-19
ES2055875T3 (es) 1994-09-01
ATE88188T1 (de) 1993-04-15
FR2644064A1 (fr) 1990-09-14
DK0383645T3 (da) 1993-08-02

Similar Documents

Publication Publication Date Title
DE60014047D1 (de) Verfahren zur reinigung von milchsäure auf industrieller basis
IE860305L (en) Method for purifying antihemophilic factor
DE69201959T2 (de) Verfahren zur Herstellung von 6,12-Dihydro-6-hydroxy-cannabidiol und dessen Anwendung zur Herstellung von trans-delta-9-Tetrahydrocannabinol.
HU905333D0 (en) Process for producing cyclic amino-acid derivatives
FI102962B1 (fi) Menetelmä ksylitolin valmistamiseksi
DE3853610D1 (de) Verfahren zur Proteinreinigung.
DE3886237D1 (de) Reinigung von LFA-3.
DE69001309D1 (de) Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.
ATE131490T1 (de) Verfahren zur herstellung von gereinigten albuminlösungen
EP0317627A4 (en) Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
DE69010405D1 (de) Verfahren zur Herstellung von R(+)-Aminocarnitin und S(-)-Aminocarnitin.
ATE116636T1 (de) Verfahren zur herstellung von 2,6- dichlordiphenylaminessigsäurederivaten.
ATE173272T1 (de) Verfahren zur reaktivierung von gereinigten membranproteinen
DE3855002T2 (de) Verfahren zur Herstellung von Dodecahydro-3a,6,6,9a-tetramethylnaphto(2,1-b)furan
DE69411492D1 (de) Verfahren zur Reinigung von mittleren Olefinen
EP0323842A3 (de) Methode für die Säuberung von umbildendem Wachstums-Faktor-Beta
ATE81496T1 (de) Verfahren zur reinigung von dihydroxybiphenylen.
ATE137758T1 (de) Verfahren zur herstellung von nojirimycin- verbindungen
ATE35679T1 (de) Verfahren zur herstellung von cis-3,3,5trimethylcyclohexyl-d,l-alpha-(3-pyridincarboxy - phenylacetat.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8339 Ceased/non-payment of the annual fee